BMP-2 but not VEGF or PDGF in fibrin matrix supports bone healing in a delayed-union rat model

Journal of Orthopaedic Research

Volumn 30, Issue 10, 2012, Pages 1563-1569

  Kaipel, Martin ^a,b   Schützenberger, Sebastian ^b   Schultz, Arthur ^b   Ferguson, James ^b   Slezak, Paul ^b   Morton, Tatjana J ^b   Van Griensven, Martijn ^b   Redl, Heinz ^b  

^a KRANKENHAUS DER BARMHERZIGEN BRÜDER   (Austria)

^b LUDWIG BOLTZMANN INSTITUTE FOR LUNG VASCULAR RESEARCH   (Austria)

Author keywords

BMP 2; delayed union; fibrin; PDGF; VEGF

Indexed keywords

FIBRIN GLUE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT PLATELET DERIVED GROWTH FACTOR BB; SILICONE; VASCULOTROPIN 165;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; FIBRIN CLOT; FRACTURE HEALING; FRACTURE NONUNION; MALE; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; RAT; SURGICAL INFECTION; VASCULARIZATION;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; FEMORAL FRACTURES; FEMUR; FIBRIN; FRACTURE HEALING; FRACTURES, UNUNITED; MALE; PLATELET-DERIVED GROWTH FACTOR; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84865529859     PISSN: 07360266     EISSN: 1554527X     Source Type: Journal    
DOI: 10.1002/jor.22132     Document Type: Article

References (27)

1. Schmidmaier G, Schwabe P, Wildemann B, et al. 2007. Use of bone morphogenetic proteins for treatment of non-unions and future perspectives. Injury 38: S35-S41. (Pubitemid 351162870)
2. Megas P., 2005. Classification of non-union. Injury 36: S30-S37.
3. Drosse I, Volkmer E, Capanna R, et al. 2008. Tissue engineering for bone defect healing: an update on a multi-component approach. Injury 39: S9-S20.
4. Hollinger JO, Onikepe AO, MacKrell J, et al. 2008. Accelerated fracture healing in the geriatric, osteoporotic rat with recombinant human platelet-derived growth factor-BB and an injectable beta-tricalcium phosphate/collagen matrix. J Orthop Res 26: 83-90.
5. Nash TJ, Howlett CR, Martin C, et al. 1994. Effect of platelet-derived growth factor on tibial osteotomies in rabbits. Bone 15: 203-208. (Pubitemid 24116085)
6. Ranly DM, Lohmann CH, Andreacchio D, et al. 2007. Platelet-rich plasma inhibits demineralized bone matrix-induced bone formation in nude mice. J Bone Joint Surg Am 89: 139-147. (Pubitemid 46059153)
7. Beamer B, Hettrich C, Lane J., 2010. Vascular endothelial growth factor: an essential component of angiogenesis and fracture healing. HSSJ 6: 85-94.
8. Kempen DH, Lu L, Heijink A, et al. 2009. Effect of local sequential VEGF and BMP-2 delivery on ectopic and orthotopic bone regeneration. Biomaterials 30: 2816-2825.
9. Patel ZS, Young S, Tabata Y, et al. 2008. Dual delivery of an angiogenic and an osteogenic growth factor for bone regeneration in a critical size defect model. Bone 43: 931-940.
10. Young S, Patel ZS, Kretlow JD, et al. 2009. Dose effect of dual delivery of vascular endothelial growth factor and bone morphogenetic protein-2 on bone regeneration in a rat critical-size defect model. Tissue Eng Part A 15: 2347-2362.
11. Eckardt H, Ding M, Lind M, et al. 2005. Recombinant human vascular endothelial growth factor enhances bone healing in an experimental nonunion model. J Bone Joint Surg Br 87: 1434-1438. (Pubitemid 41511813)
12. Li R, Stewart DJ, von Schroeder HP, et al. 2009. Effect of cell-based VEGF gene therapy on healing of a segmental bone defect. J Orthop Res 27: 8-14.
13. Street J, Bao M, deGuzman L, et al. 2002. Vascular endothelial growth factor stimulates bone repair by promoting angiogenesis and bone turnover. Proc Natl Acad Sci USA 99: 9656-9661. (Pubitemid 34831103)
14. Spicer PP, Mikos AG., 2010. Fibrin glue as a drug delivery system. J Control Release 148: 49-55.
15. Schmökel HG, Weber FE, Seiler G, et al. 2004. Treatment of nonunions with non glycosylated recombinant human bone morphogenetic protein-2 delivered from a fibrin matrix. Vet Surg 33: 112-118. (Pubitemid 41755001)
16. Mittermayr R, Morton T, Hofmann M, et al. 2008. Sustained (rh)VEGF(165) release from a sprayed fibrin biomatrix induces angiogenesis, up-regulation of endogenous VEGF-R2, and reduces ischemic flap necrosis. Wound Repair Regen 16: 542-550. (Pubitemid 352000310)
17. Thomopoulos S, Das R, Silva MJ, et al. 2009. Enhanced flexor tendon healing through controlled delivery of PDGF-BB. J Orthop Res 27: 1209-1215.
18. Schmidhammer R, Zandieh S, Mittermayr R, et al. 2006. Assessment of bone union/nonunion in an experimental model using microcomputed technology. J Trauma 61: 199-205. (Pubitemid 44098345)
19. Friedlaender GE, Perry CR, Cole JD, et al. 2001. Osteogenic protein-1 (bone morphogenetic protein-7) in the treatment of tibial nonunions. J Bone Joint Surg Am 83-A: S151-S158.
20. Heckman JD, Boyan BD, Aufdemorte TB, et al. 1991. The use of bone morphogenetic protein in the treatment of non-union in a canine model. J Bone Joint Surg Am 73: 750-764.
21. Johnson EE, Urist MR., 2000. Human bone morphogenetic protein allografting for reconstruction of femoral nonunion. Clin Orthop Relat Res 371: 61-74. (Pubitemid 30090822)
22. Kanakaris NK, Paliobeis C, Nlanidakis N, et al. 2007. Biological enhancement of tibial diaphyseal aseptic non-unions: the efficacy of autologous bone grafting, BMPs and reaming by-products. Injury 38: S65-75. (Pubitemid 47498408)
23. Kubota K, Sakikawa C, Katsumata M, et al. 2002. Platelet-derived growth factor BB secreted from osteoclasts acts as an osteoblastogenesis inhibitory factor. J Bone Miner Res 17: 257-265. (Pubitemid 34087658)
24. Marden LJ, Fan RS, Pierce GF, et al. 1993. Platelet-derived growth factor inhibits bone regeneration induced by osteogenin, a bone morphogenetic protein, in rat craniotomy defects. J Clin Invest 92: 2897-2905. (Pubitemid 24006560)
25. Benjamin LE, Hemo I, Keshet E., 1998. A plasticity window for blood vessel remodelling is defined by pericyte coverage of the preformed endothelial network and is regulated by PDGF-B and VEGF. Development 125: 1591-1598. (Pubitemid 28256727)
26. Al-Zube L, Breitbart EA, O'Connor JP, et al. 2009. Recombinant human platelet derived growth factor (rhPDGF-BB) and beta-tricalcium phosphate/collagen matrix enhance fracture healing in a diabetic fracture model. J Orthop Res 27: 1074-1081.
27. Xu L, Lv K, Zhang W, et al. 2012. The healing of critical-size calvarian bone defects in rat with rhPDGF-BB, BMSCs and β-TCP scaffolds. J Mater Sci Mater Med 23: 1073-1084.